| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1045215957 |
| P356 | DOI | 10.1038/MODPATHOL.3800336 |
| P698 | PubMed publication ID | 15605080 |
| P5875 | ResearchGate publication ID | 8125072 |
| P2093 | author name string | Chao-Cheng Huang | |
| Jiin-Haur Chuang | |||
| Jui-Wei Lin | |||
| Tsung-Hui Hu | |||
| Chia-Ling Wu | |||
| Pey-Ru Lin | |||
| Ming Hong Tai | |||
| Shang-Yun Liu | |||
| P2860 | cites work | Expression of hepatocyte growth factor and its receptor c-met proto-oncogene in hepatocellular carcinoma | Q73208981 |
| Angiogenic cytokines in serum and plasma of patients with head and neck squamous cell carcimona | Q73311618 | ||
| Expression of vascular endothelial growth factor in surgical specimens of hepatocellular carcinoma | Q73605688 | ||
| Serum endostatin levels are elevated in patients with soft tissue sarcoma | Q73746419 | ||
| Serum endostatin levels in patients with hepatocellular carcinoma | Q74170706 | ||
| A prospective analysis of plasma endostatin levels in colorectal cancer patients with liver metastases | Q74612471 | ||
| Hepatocytes as a source of collagen type XVIII endostatin | Q77318064 | ||
| Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma | Q78330664 | ||
| Serum endostatin predicts tumor vascularity in hepatocellular carcinoma | Q78462843 | ||
| Endostatin: an endogenous inhibitor of angiogenesis and tumor growth | Q24315369 | ||
| Interaction of endostatin with integrins implicated in angiogenesis | Q24545535 | ||
| Lack of collagen XVIII/endostatin results in eye abnormalities | Q28511317 | ||
| Modulation of collagen XVIII/endostatin expression in lobular and biliary rat liver fibrogenesis | Q28577092 | ||
| Mouse Col18a1 is expressed in a tissue-specific manner as three alternative variants and is localized in basement membrane zones | Q28591231 | ||
| Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma | Q29615947 | ||
| A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin | Q33763790 | ||
| Complete primary structure of two variant forms of human type XVIII collagen and tissue-specific differences in the expression of the corresponding transcripts. | Q34460521 | ||
| Collagen type XVIII/endostatin is differentially expressed in primary and metastatic colorectal cancers and ovarian carcinomas | Q36623179 | ||
| Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma | Q43049041 | ||
| Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma | Q47791327 | ||
| Clinical significance of microvessel density and vascular endothelial growth factor expression in hepatocellular carcinoma and surrounding liver: Possible involvement of vascular endothelial growth factor in the angiogenesis of cirrhotic liver | Q47993681 | ||
| Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance | Q50626711 | ||
| A cancer therapy resistant to resistance | Q59070138 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 663-672 | |
| P577 | publication date | 2005-05-01 | |
| P1433 | published in | Modern Pathology | Q15724578 |
| P1476 | title | Increased endostatin/collagen XVIII expression correlates with elevated VEGF level and poor prognosis in hepatocellular carcinoma. | |
| P478 | volume | 18 |
| Q34213827 | A 3′ UTR SNP in COL18A1 Is Associated with Susceptibility to HBV Related Hepatocellular Carcinoma in Chinese: Three Independent Case-Control Studies |
| Q36235557 | Antiangiogenic strategies in hepatocellular carcinoma: current status |
| Q34233029 | Correlation analysis of liver tumor-associated genes with liver regeneration |
| Q27002610 | Correlation of serum levels of endostatin with tumor stage in gastric cancer: a systematic review and meta-analysis |
| Q36220259 | Endostatin's emerging roles in angiogenesis, lymphangiogenesis, disease, and clinical applications. |
| Q33837248 | Eupafolin Exhibits Potent Anti-Angiogenic and Antitumor Activity in Hepatocellular Carcinoma |
| Q43468044 | Functionally conserved cis-regulatory elements of COL18A1 identified through zebrafish transgenesis |
| Q34630306 | Molecular and serum markers in hepatocellular carcinoma: Predictive tools for prognosis and recurrence |
| Q36419264 | Mutations in collagen 18A1 and their relevance to the human phenotype |
| Q39719714 | Prognostic relevance of collagen XVIII expression in metastatic gastric carcinoma |
| Q57294531 | Proteoglycans Are Attractive Biomarkers and Therapeutic Targets in Hepatocellular Carcinoma |
| Q35679807 | Proteolytically Derived Endogenous Angioinhibitors Originating from the Extracellular Matrix |
| Q37901677 | Role of the microenvironment in hepatocellular carcinoma development and progression |
| Q84623663 | Serial serum VEGF‐A, angiopoietin‐2, and endostatin measurements in cirrhotic patients with hepatocellular carcinoma treated by transcatheter arterial chemoembolization |
| Q83140292 | Serum endostatin levels in patients with metastatic and non-metastatic well-differentiated thyroid cancer |
| Q45339888 | Serum levels of angiogenic and anti-angiogenic factors: their prognostic relevance in locally advanced hepatocellular carcinoma |
Search more.